Caring Ambassadors Program Hepatitis C Literature Review © 2016 Caring Ambassadors Program Hepatitis C Newsletter www.HepCChallenge.org

Caring Ambassadors Program Hepatitis C Literature Review © 2015 Caring Ambassadors Program Hepatitis C Newsletter www.HepCChallenge.org

Caring Ambassadors Program Hepatitis C Literature Review © 2015 Caring Ambassadors Program Hepatitis C Newsletter www.HepCChallenge.org

Caring Ambassadors Program Hepatitis C Literature Review © 2018 Caring Ambassadors Program Hepatitis C Newsletter www.HepCChallenge.org

Successful retreatment with sofosbuvir plus ledipasvir for cirrhotic patients with hepatitis C virus genotype 1b, who discontinued the prior treatment with asunaprevir plus daclatasvir: A case series and review of the literature. Haga Y1, Kanda T1,2, Yasui S1, et al. Oncotarget. 2017 Dec 29;9(4):5509-5513. doi: 10.18632/oncotarget.23768. eCollection 2018 Jan 12. BACKGROUND: Interferon-free trea...

Caring Ambassadors Program Hepatitis C Literature Review © 2013 Caring Ambassadors Program Hepatitis C Newsletter www.HepCChallenge.org

High proportion of hepatitis C virus in community Asian American patients with nonliver-related complaints. Kin KC, Lin B, Ha NB, et al. J Clin Gastroenterol. 2013 Apr;47(4):367-71. doi: 10.1097/MCG.0b013e3182688b3e. http://www.ncbi.nlm.nih.gov/pubmed/23090039 GOALS AND BACKGROUND: Besides United States population born between 1945 and 1965, screening for hepatitis C virus (HCV) is not recommen...

Caring Ambassadors Program Hepatitis C Literature Review © 2017 Caring Ambassadors Program Hepatitis C Newsletter www.HepCChallenge.org

Results of sofosbuvir-based combination therapy for chronic hepatitis C cohort of Indian patients in real-life clinical practice. Sood A1, Midha V2, Mahajan R1, et al. J Gastroenterol Hepatol. 2017 Apr;32(4):894-900. doi: 10.1111/jgh.13628. BACKGROUND AND AIM: The introduction of sofosbuvir has revolutionized the treatment of chronic hepatitis C. This study was planned to observe whether the ef...